Seoul: Hanall Biopharma Co. on Wednesday reported its first-quarter net loss of 208 million won (US$146,407), remaining in the red compared with a year ago.

According to Yonhap News Agency, the company revealed in a regulatory filing that it posted an operating loss of 394 million won for the January-March period, a significant downturn from a profit of 119 million won a year earlier. Despite the losses, Hanall Biopharma experienced a 6 percent increase in sales, reaching 36.2 billion won.